News
21h
MedPage Today on MSNCVS Drops Obesity Drug; Once-Weekly Growth Hormone; WeightWatchers' BankruptcyPeople prescribed GLP-1 agents liraglutide (Saxenda) or semaglutide for weight loss decreased their alcohol intake by almost ...
Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid ...
Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after legislators pass ...
In 2023, the Blue Shield of California announced that it was dropping CVS Caremark as its pharmacy benefit manager (PBM) and ...
11h
LAist on MSNGavin Newsom says these middlemen drive up drug prices. He’s got a new plan to fix itGov. Gavin Newsom will seek to regulate pharmaceutical middlemen that he blames for driving up prescription drug costs in ...
Gov. Gavin Newsom announced today that he will seek to regulate prescription drug middlemen that he blames for driving up ...
Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.
21hon MSN
Seeking to lower prescription drug prices and safeguard abortion access, Gov. Gavin Newsom on Tuesday proposed new ...
1h
Investor's Business Daily on MSNNovo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna SkyrocketingNovo Nordisk inked an obesity deal worth up to $2.2 billion on Wednesday, and sent shares of Septerna into the stratosphere.
Gov. Gavin Newsom announced Tuesday that he will seek to regulate prescription drug managers he blames for driving up costs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results